Skip to main content

Biogen Inc (BIIB-Q) Quote

Register
AdChoices
Unchecking box will stop auto data updates
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 299.00
Day High 304.56
Open:299.68
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Latest
u.s. business
Biogen shares soar 27 per cent on resurrection of planned Alzheimer’s treatment
Subscriber content
number cruncher
Value investors should check out these 15 U.S. large caps
Subscriber content
inside the market
Market movers: Stocks seeing action on Friday - and why
Subscriber content
number cruncher
Fifteen U.S. health-care stocks back on investors’ radars
Subscriber content
inside the market
What every Canadian investor needs to know today
Subscriber content
number cruncher
Why these five tech stocks may be much cheaper than you think
Subscriber content
Description
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

View Earnings zacks

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

View Estimates zacks

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Download Report (PDF) Thomson Reuters

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Download Report (PDF) StockCalc

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Download Report (PDF) ValueEnfine

Latest Press Releases

More Stories
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (ACAD , BIIB , FLXN , DVAX , GBT )
- Comtex SmarTrend(R) - Fri Dec 6, 2:27AM CST
Comtex SmarTrend(R) - CMTX
Fri Dec 6, 2:27AM CST
Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming. This is what we found:
Biogen Announces Positive Phase 2 Study Results for Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE)
- Globe Newswire - Tue Dec 3, 6:30AM CST
Globe Newswire - CMTX
Tue Dec 3, 6:30AM CST
- The Phase 2 LILAC study met its primary endpoints, demonstrating statistically significant reduction of disease activity in patients with CLE and SLE who received BIIB059 compared to placebo
Watch for Biogen Inc to Potentially Rebound After Falling 1.28% Yesterday
- Comtex SmarTrend(R) - Mon Dec 2, 11:03AM CST
Comtex SmarTrend(R) - CMTX
Mon Dec 2, 11:03AM CST
Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $290.16 to a high of $296.57. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $298.68 on volume of 281,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 271.48 +11.62% increase
on 11/14/19
Period Open:289.00
Price movement based on the high, low and last over the given period.
309.06 -1.95% decrease
on 12/05/19
 +14.03 (+4.85%) increase
since 11/06/19
3-Month 219.70 +37.93% increase
on 10/03/19
Period Open:224.57
Price movement based on the high, low and last over the given period.
318.00 -4.71% decrease
on 10/22/19
 +78.46 (+34.94%) increase
since 09/06/19
52-Week 215.77 +40.44% increase
on 09/04/19
Period Open:326.70
Price movement based on the high, low and last over the given period.
344.00 -11.91% decrease
on 01/23/19
 -23.67 (-7.25%) decrease
since 12/06/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies